Anti-biofilm effect by the combined action of fluconazole and acetylsalicylic acid against species of Candida parapsilosis complex.

The Candida parapsilosis complex has been associated with highly refractory infections mainly due to the presence of biofilms. High glucose levels enable the development of this virulence factor which can aggravate the clinical condition of patients with diabetes mellitus, those using parenteral nutrition, with invasive medical device, including others. Combined antifungal therapy, such as azole and cyclooxygenase inhibitors, may be an alternative in such infections since they modulate prostaglandin production favoring the adhesion and development of biofilms. Thus, the present study aimed to evaluate the influence of glucose supplementation in the formation and detection of Candida parapsilosis complex biofilms and to treat them using fluconazole and a cyclooxygenase inhibitor in combination. Protein spectra evaluation allowed the differentiation between species from the complex (score > 2) in our studies. All isolates were able to form active biofilms at different glucose concentrations. In addition, a significant reduction in biofilm formation was observed when fluconazole and acetylsalicylic acid were combined. The ultrastructural analysis presented typical biofilm characteristics by species from the complex. These data support new combined therapies for the treatment of fungal infections, especially with those which are resistant and therapeutic failure is associated with virulence factors.

Avaliação In vitro da atividade antimicrobiana e moduladora dos extratos etanólico e hexânico de bulbo de Costus arabicus / In vitro evaluation of antimicrobial activity and modulating the ethanol and hexane extracts of Costus arabicus bulb

Neste estudo, extratos etanólicos e hexânicos de bulbo de Costus arabicus foram utilizados com o objetivo de avaliar a atividade antibacteriana, antifúngica e moduladora da resistencia de antibacterianos e antifúnicos contra cepas bactecterianas de Escherichia Coli, Staphylococcus aureus, Pseudomonas aeruginosa e cepas fúngicas de Candida Albicans. Candida Krusei, Candida Tropicalis. A atividade antibacteriana e modulatória foi determinada por microdiluição. A inibição do crescimento das bactérias e fungos testados com extrato foi ≥1024. A atividade de alguns antibióticos e antifúngicos foi reforçada sinergicamente quando estes extratos foram associados em concentrações subinibitórias com antimicrobianos. Portanto, sugerimos que os extratos etanólicos e hexânicos de bulbo de Costus arabicus podem ser utilizados como fonte de produtos naturais com o objetivo de modificar a resistência desses microorganismos aos antimicrobianos.

In this study, ethanol and hexane extracts of the bulbs from Costus Arabicus were assayed to antibacterial, antifungal and modulatory activity against antibacterial and antifungal drugs using bacterial and fungal strains of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans, C. krusei and C. tropicalis. The antimicrobial and modulatory activity was evaluated by microdilution method. The activity of some antimicrobial drugs was synergistically enhanced when sub-inhibitory concentrations of these extracts were associated with antimicrobial drugs. Therefore, we suggest that ethanol and hexane extracts of bulbs from Costus Arabicus can be used as a source of natural products in order to modify the resistance of these microorganisms to antimicrobials, demonstrating an interesting strategy to combat drug-resistant infectious agents.